CAS 4238-35-1
:1,8,15,22-Tetraazacyclooctacosane-2,7,16,21-tetrone
Description:
1,8,15,22-Tetraazacyclooctacosane-2,7,16,21-tetrone, with the CAS number 4238-35-1, is a complex organic compound characterized by its unique cyclic structure and multiple nitrogen atoms integrated into its framework. This compound features a macrocyclic arrangement, which contributes to its stability and potential applications in coordination chemistry. The presence of four carbonyl (ketone) functional groups at specific positions enhances its reactivity and ability to form coordination complexes with metal ions. The tetraazacyclooctacosane backbone provides a rigid structure that can influence the compound's solubility and interaction with other molecules. Due to its intricate structure, this compound may exhibit interesting properties such as chelation, which can be useful in various fields, including catalysis, materials science, and medicinal chemistry. Its synthesis and characterization often require advanced techniques due to the complexity of its molecular architecture. Overall, this compound represents a fascinating area of study within the realm of organic and inorganic chemistry.
Formula:C24H44N4O4
Synonyms:- 1,8,15,22-Tetraazacyclooctacosane-2,7,16,21-tetrone
- 1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
1,8,15,22-Tetraazacyclooctacosane-2,7,16,21-tetrone
CAS:Formula:C24H44N4O4Purity:95%Color and Shape:SolidMolecular weight:452.63061,8,15,22-Tetraazacyclooctacosane-2,7,16,21-tetrone
CAS:Formula:C24H44N4O4Purity:>95%Molecular weight:452.641,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone
CAS:<p>1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone is an inhibitor with potent anticancer properties. It induces apoptosis in cancer cells by inhibiting kinases that are critical for cell survival and proliferation. This compound has been shown to be effective against various types of cancer in both Chinese hamster ovary and human cancer cell lines. Additionally, it has been found to increase the excretion of the anti-allergic drug rupatadine in urine. The use of 1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone as a tumor inhibitor has also been investigated in combination with other kinase inhibitors such as bendamustine analogs. This compound holds great potential for the development of new anticancer therapies.</p>Formula:C24H44N4O4Purity:Min. 95%Molecular weight:452.6 g/mol




